|

Prevention of Caries in Head and Neck Cancer Survivors Who Underwent Radiotherapy

RECRUITINGN/ASponsored by University of Milan
Actively Recruiting
PhaseN/A
SponsorUniversity of Milan
Started2023-04-01
Est. completion2026-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

One of the long-term side effects of head and neck radiotherapy (RT) is radiation-induced tooth decay. Hyposalivation, associated with radiation therapy, further increases caries susceptibility and caries progression, due to the lack of salivary protective effects and of tooth minerals useful for remineralization processes, especially calcium phosphate (CaP). Dental extractions that could be required in case of severe tooth decay expose the patient to the risk of osteoradionecrosis of the jaws (i.e. the necrosis of the bone tissue following a local trauma, including surgical trauma). This protocol aims at verifying the effectiveness of CaP mousse in the prevention of carious lesions, added to topical fluoride. A randomized controlled clinical trial will be performed comparing CaP + fluoride treatment versus no treatment in head and neck cancer patients, who received radiotherapy. The hypothesis is that CaP, which is lacking in the mouth of these patients due to hyposalivation, can combine with fluoride to promote remineralization, reducing the risk of carious lesions.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* previous head and neck radiotherapy for oncological treatment

Exclusion Criteria:

* complete edentulism
* pregnancy or breastfeeding

Conditions4

CancerCaries,DentalHead and Neck CancerRadiotherapy; Complications

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.